PL390611A1 - Process for the preparation of polymorphic alpha form and new polymorphic form of imatinib mesylate - Google Patents

Process for the preparation of polymorphic alpha form and new polymorphic form of imatinib mesylate

Info

Publication number
PL390611A1
PL390611A1 PL390611A PL39061110A PL390611A1 PL 390611 A1 PL390611 A1 PL 390611A1 PL 390611 A PL390611 A PL 390611A PL 39061110 A PL39061110 A PL 39061110A PL 390611 A1 PL390611 A1 PL 390611A1
Authority
PL
Poland
Prior art keywords
polymorphic
preparation
imatinib mesylate
new
alpha
Prior art date
Application number
PL390611A
Other languages
Polish (pl)
Inventor
Tomasz Koźluk
Robert Woźniak
Original Assignee
Tomasz Koźluk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomasz Koźluk filed Critical Tomasz Koźluk
Priority to PL390611A priority Critical patent/PL390611A1/en
Priority to EP11715079A priority patent/EP2542548A1/en
Priority to PCT/PL2011/000028 priority patent/WO2011108953A1/en
Publication of PL390611A1 publication Critical patent/PL390611A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL390611A 2010-03-04 2010-03-04 Process for the preparation of polymorphic alpha form and new polymorphic form of imatinib mesylate PL390611A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL390611A PL390611A1 (en) 2010-03-04 2010-03-04 Process for the preparation of polymorphic alpha form and new polymorphic form of imatinib mesylate
EP11715079A EP2542548A1 (en) 2010-03-04 2011-03-04 Process for preparation of polymorphic form and new polymorphic form of imatinib mesylate isolated in that process
PCT/PL2011/000028 WO2011108953A1 (en) 2010-03-04 2011-03-04 PROCESS FOR PREPARATION OF POLYMORPHIC FORM α AND NEW POLYMORPHIC FORM OF IMATINIB MESYLATE ISOLATED IN THAT PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL390611A PL390611A1 (en) 2010-03-04 2010-03-04 Process for the preparation of polymorphic alpha form and new polymorphic form of imatinib mesylate

Publications (1)

Publication Number Publication Date
PL390611A1 true PL390611A1 (en) 2011-09-12

Family

ID=44069990

Family Applications (1)

Application Number Title Priority Date Filing Date
PL390611A PL390611A1 (en) 2010-03-04 2010-03-04 Process for the preparation of polymorphic alpha form and new polymorphic form of imatinib mesylate

Country Status (3)

Country Link
EP (1) EP2542548A1 (en)
PL (1) PL390611A1 (en)
WO (1) WO2011108953A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013110058A (en) * 2010-08-11 2014-09-20 Синтон Б.В. PHARMACEUTICAL GRANULATE CONTAINING IMATINIB MESILATE
ITMI20111309A1 (en) * 2011-07-14 2013-01-15 Italiana Sint Spa PREPARATION PROCEDURE OF IMATINIB MESILATO
EP2604596A1 (en) * 2011-12-16 2013-06-19 Deva Holding Anonim Sirketi Polymorphs of imatinib
WO2013136141A1 (en) 2012-03-13 2013-09-19 Fresenius Kabi Oncology Ltd. An improved process for the preparation of alpha form of imatinib mesylate
CN103044396A (en) * 2012-12-14 2013-04-17 浙江华海药业股份有限公司 Preparation method of imatinib mesylate alpha-form crystal
AU2014279765A1 (en) * 2013-06-12 2015-12-17 Shilpa Medicare Limited Crystalline Imatinib mesylate process

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (en) 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (en) 1997-07-18 2000-07-24 Novartis Ag MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
AU2003237596A1 (en) 2003-06-02 2005-01-21 Hetero Drugs Limited Novel polymorphs of imatinib mesylate
WO2005077933A1 (en) 2004-02-11 2005-08-25 Natco Pharma Limited Novel polymorphic form of imatinib mesylate and a process for its preparation
UA84462C2 (en) 2004-04-02 2008-10-27 Институт Фармацевтични Crystalline polymorphs of methanesulfonic acid addition salts of imatinib
WO2006048890A1 (en) 2004-11-04 2006-05-11 Sun Pharmaceutical Industries Limited Imatinib mesylate crystal form and process for preparation thereof
WO2006054314A1 (en) 2004-11-17 2006-05-26 Natco Pharma Limited Polymorphic forms of imatinib mesylate
DE502006005084D1 (en) 2005-08-15 2009-11-26 Siegfried Generics Int Ag Film-coated tablet or granules containing a pyridylpyrimidine
EP1922314A1 (en) 2005-08-26 2008-05-21 Novartis AG Delta and epsilon crystal forms of imatinib mesylate
CN102351842B (en) 2005-11-25 2014-07-23 诺华股份有限公司 F,G,H,I and K crystal forms of imatinib mesylate
US7977348B2 (en) * 2006-04-27 2011-07-12 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
EP2291366A4 (en) * 2008-05-26 2012-06-06 Reddys Lab Ltd Dr Preparation of imatinib mesylate

Also Published As

Publication number Publication date
WO2011108953A1 (en) 2011-09-09
EP2542548A1 (en) 2013-01-09

Similar Documents

Publication Publication Date Title
IL221471A0 (en) Process for the preparation of alpha form of imatinib mesylate
ZA201202504B (en) Process for the preparation of calcobutrol
IL258239A (en) Polymorphic forms st-246 and methods of preparation
EP2291366A4 (en) Preparation of imatinib mesylate
ZA201204365B (en) Darunavir polymorph and process for preparation thereof
SI2582689T1 (en) New polymorphic form of imatinib base and preparation of salts thereof
EP2539444A4 (en) Compositions and methods for the production of l-homoalanine
EP2630143A4 (en) Processes for the preparation of rivaroxaban and intermediates thereof
PL390042A1 (en) Process for the preparation of kvass
ZA201202343B (en) Process for the preparation of lenalidomide
EP2691385A4 (en) Improved process for preparation of imatinib and its mesylate salt
PL390611A1 (en) Process for the preparation of polymorphic alpha form and new polymorphic form of imatinib mesylate
ZA201207397B (en) Process for the preparation of dexlansoprazole
PL388931A1 (en) Process for the preparation of fluorocarbfunctional silesquioxanes
EP2596007A4 (en) Process for the preparation of 17-desoxy-corticosteroids
EP2571836A4 (en) Process for the preparation of hexafluoro-2-butyne
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
PT2603319E (en) Process for the preparation of urethans
EP2467375A4 (en) Forms of dexlansoprazole and processes for the preparation thereof
PT2390246T (en) Process for the preparation of aminaphtone
EP2647632A4 (en) Preparation method of a-imatinib mesylate
PT2598504E (en) Process for the preparation of dimiracetam
PL389013A1 (en) New vinyl-alkinylsubstituted germanium compounds and process for the preparation of vinyl-alkinylsubstituted germanium compounds
PL391702A1 (en) Process for the preparation of 5-hydroxycreatinine and N-methylguanidine
PL393415A1 (en) New bivinyl-alkinylsubstituted silicon- and siliconboronorganic compounds and process for the preparation of bivinyl-alkinylsubstituted silicon- and siliconboronorganic compounds

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)